Predictive factors for outcome and response in patients treated with second-generation tyrosine kinase inhibitors for chronic myeloid leukemia in chronic phase after imatinib failure

We assessed the predictive factors for outcome and response in 123 patients with chronic myeloid leukemia in chronic phase treated with second-generation tyrosine kinase inhibitors (TKIs) after imatinib failure. Better event-free survival rates with second-generation TKI therapy were associated with...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Main Authors: Jabbour, Elias, Kantarjian, Hagop, O'Brien, Susan, Shan, Jenny, Garcia-Manero, Guillermo, Wierda, William, Ravandi, Farhad, Borthakur, Gautam, Rios, Mary Beth, Cortes, Jorge
Formáid: Artigo
Teanga:Inglês
Foilsithe: American Society of Hematology 2011
Ábhair:
Clinical Trials and Observations
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4081281/
https://ncbi.nlm.nih.gov/pubmed/21030554
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2010-07-293977
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla